133 related articles for article (PubMed ID: 8280615)
1. Reversing of chlorambucil resistance by ethacrynic acid in a B-CLL patient.
Petrini M; Conte A; Caracciolo F; Sabbatini A; Grassi B; Ronca G
Br J Haematol; 1993 Oct; 85(2):409-10. PubMed ID: 8280615
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance mechanisms in chronic lymphocytic leukemia.
Ribrag V; Massade L; Faussat AM; Dreyfus F; Bayle C; Gouyette A; Marie JP
Leukemia; 1996 Dec; 10(12):1944-9. PubMed ID: 8946935
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of resistance to chlorambucil in chronic lymphocytic leukemia.
Begleiter A; Goldenberg GJ; Anhalt CD; Lee K; Mowat MR; Israels LG; Johnston JB
Leuk Res; 1991; 15(11):1019-27. PubMed ID: 1961006
[TBL] [Abstract][Full Text] [Related]
4. Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients.
Schisselbauer JC; Silber R; Papadopoulos E; Abrams K; LaCreta FP; Tew KD
Cancer Res; 1990 Jun; 50(12):3562-8. PubMed ID: 2340505
[TBL] [Abstract][Full Text] [Related]
5. Chlorambucil in chronic lymphocytic leukemia: mechanism of action.
Begleiter A; Mowat M; Israels LG; Johnston JB
Leuk Lymphoma; 1996 Oct; 23(3-4):187-201. PubMed ID: 9031099
[TBL] [Abstract][Full Text] [Related]
6. Glutathione-S-transferase activity and multidrug resistance phenotype in chronic lymphocytic leukemia: do they have any clinical relevance?
Di Simone D; Testi R; Caracciolo F; Capochiani E; Ambrogi F; Grassi B; Petrini M
Haematologica; 1995; 80(2):103-7. PubMed ID: 7543067
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase activity, sulfhydryl group and glutathione levels, and DNA cross-linking activity with chlorambucil in chronic lymphocytic leukemia.
Johnston JB; Israels LG; Goldenberg GJ; Anhalt CD; Verburg L; Mowat MR; Begleiter A
J Natl Cancer Inst; 1990 May; 82(9):776-9. PubMed ID: 2325147
[TBL] [Abstract][Full Text] [Related]
8. Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemia.
Goede V; Eichhorst B; Fischer K; Wendtner CM; Hallek M
Leuk Lymphoma; 2015 Jun; 56(6):1585-92. PubMed ID: 25219593
[TBL] [Abstract][Full Text] [Related]
9. [Effect of chlorambucil on B-lymphocytes in the peripheral blood of patients with chronic lymphocytic leukemia--study of cellular ultrastructure].
Brajusković G; Marjanović S; Skaro-Milić A
Vojnosanit Pregl; 2003; 60(2):175-80. PubMed ID: 12852160
[TBL] [Abstract][Full Text] [Related]
10. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
Dighiero G; Maloum K; Desablens B; Cazin B; Navarro M; Leblay R; Leporrier M; Jaubert J; Lepeu G; Dreyfus B; Binet JL; Travade P
N Engl J Med; 1998 May; 338(21):1506-14. PubMed ID: 9593789
[TBL] [Abstract][Full Text] [Related]
11. In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features.
Morabito F; Stelitano C; Callea I; Filangeri M; Oliva B; Sculli G; Callea V; Nobile F; Brugiatelli M
Haematologica; 1996; 81(3):224-31. PubMed ID: 8767527
[TBL] [Abstract][Full Text] [Related]
12. Towards improved frontline treatment of CLL in the elderly.
Goede V; Hallek M
Lancet; 2015 May; 385(9980):1814-5. PubMed ID: 25882395
[No Abstract] [Full Text] [Related]
13. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines.
Tew KD; Bomber AM; Hoffman SJ
Cancer Res; 1988 Jul; 48(13):3622-5. PubMed ID: 3288331
[TBL] [Abstract][Full Text] [Related]
14. Role of glutathione and glutathione S-transferase in chlorambucil resistance.
Yang WZ; Begleiter A; Johnston JB; Israels LG; Mowat MR
Mol Pharmacol; 1992 Apr; 41(4):625-30. PubMed ID: 1569917
[TBL] [Abstract][Full Text] [Related]
15. Chlorambucil for the treatment of patients with chronic lymphocytic leukemia (CLL) - a systematic review and meta-analysis of randomized trials.
Vidal L; Gurion R; Ram R; Raanani P; Bairey O; Robak T; Gafter-Gvili A; Shpilberg O
Leuk Lymphoma; 2016 Sep; 57(9):2047-57. PubMed ID: 26980554
[TBL] [Abstract][Full Text] [Related]
16. A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients.
Hebb J; Assouline S; Rousseau C; Desjardins P; Caplan S; Egorin MJ; Amrein L; Aloyz R; Panasci L
Cancer Chemother Pharmacol; 2011 Sep; 68(3):643-51. PubMed ID: 21120481
[TBL] [Abstract][Full Text] [Related]
17. [Immunological profile of lymphoid cells in patients with chronic lymphoid leukemia and immunological complications during the treatment with prednisolone and chlorambucil].
Lohins'kyĭ VO; Karol' IuS; Tsiapka OM; Vyhovs'ka IaI
Lik Sprava; 2009; (1-2):44-9. PubMed ID: 19953990
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL.
Hillmen P; Janssens A; Babu KG; Kloczko J; Grosicki S; Manson S; McKeown A; Gupta I; Chang CN; Offner F
Acta Oncol; 2016; 55(9-10):1115-1120. PubMed ID: 27494089
[TBL] [Abstract][Full Text] [Related]
19. Role of interferon alpha-2b, chlorambucil and prednisone in the treatment of chronic lymphocytic leukemia.
Molica S
Eur J Haematol; 1992 Feb; 48(2):117-8. PubMed ID: 1547874
[No Abstract] [Full Text] [Related]
20. Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia.
Seiter K; Mamorska-Dyga A
Clin Interv Aging; 2015; 10():951-61. PubMed ID: 26109852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]